Company / Profit Margin
IRONWOOD PHARMACEUTICALS INC Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
8.1%
FY2025
5-year range
-226.4% / 127.7%
FY2021-FY2025
Trend
-81.0%
vs FY2024
Sector context
#44 of 145
Health Care
What the data says
At 8.1%, IRONWOOD PHARMACEUTICALS INC's profit margin ranks #44 of 145 in the Health Care sector. Profit Margin has fluctuated over the past 10 years, ranging from -226.4% in FY2023 to 127.7% in FY2021.
Based on SEC 10-K filings.
8.1% in FY2025 with a 5-year CAGR of +89.6%.
Improved from -226.4% to 8.1% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -19.1pp
- 5-Year Change
- +89.6pp
- 10-Year Change
- -
Sector benchmark
#44 of 145 in Health CareTop 30% of 145This company 8.1% Sector average -792.7%
▼
+101.0% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 81.0% year-over-year.
- Currently 800.8pp above the Health Care sector average.
- Peak profit margin was recorded in FY2021.
- Lowest profit margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.1% | -81.0% |
| FY2024 | 42.6% | +118.8% |
| FY2023 | -226.4% | -930.4% |
| FY2022 | 27.3% | -78.7% |
| FY2021 | 127.7% | +256.8% |
| FY2020 | -81.5% | -1722.7% |
| FY2019 | 5.0% | +116.8% |
| FY2018 | -29.8% | +86.7% |
| FY2017 | -224.2% | -651.5% |
| FY2016 | -29.8% | +68.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026